1-(2-Bromophenyl)ethylamine,
113899-55-1,
1-(2-bromophenyl)ethanamine,
1-(2-BROMO-PHENYL)-ETHYLAMINE,
1-(2'-BROMOPHENYL)ETHYLAMINE,
1-(2-bromophenyl)ethan-1-amine,
1-aminoethylbromobenzene,
ACMC-209uxs,
AC1MY2UM,
AC1Q2B8X,
ACMC-1C8J1,
2-Bromo-alpha-methylbenzylamine,
SCHEMBL1132337,
CTK6A5738,
DTXSID80396933,
ANW-16666,
MFCD05215385,
2-Bromo-alpha-methylbenzenemethanamine,
AKOS000264484,
AKOS016842780,
AS03460,
MCULE-5254179013,
RP25761,
1-(2-Bromophenyl)ethylamine, AldrichCPR,
AC-29433,
AK-50562,
AK-59163,
AK114068,
Benzenemethanamine, 2-bromo-alpha-methyl-,
DS-15489,
QC-10145,
AB0053080,
RT-005946,
4CH-002102,
4CH-014252,
4CH-024537,
ST24026834,
Z7493,
EN300-10291,
A18095,
K-1015,
J-502960,
S01-0833,
Guanidine hydrochloride,
(R)-1-(2-Bromophenyl)ethanamine,
(S)-1-(2-Bromophenyl)ethanamine,
C8H10BrN,
(1R)-1-(2-bromophenyl)ethanamine,
(1S)-1-(2-bromophenyl)ethanamine,
CID3825290,
140632-12-8,
Benzenemethanamine,2-bromo-a-methyl-, (aS)-,
113974-24-6,